MétaCan
Menu
Back to cohort
Record W4416538535 · doi:10.1186/s13643-025-02987-w

AlloDerm® versus Cortiva® in implant-based breast reconstruction: framework for a systematic review and meta-analysis of clinical and economic outcomes

2025· article· en· W4416538535 on OpenAlexaboutno aff
Yousef Tanas, Samantha Cervantes Valadez, Liam D. Cato, Peyton Harris, Keyvon Rashidi, Grace Gasper, Philong Nguyen, Joshua Wang, Sarya Swed, Peter Zak

Bibliographic record

VenueSystematic Reviews · 2025
Typearticle
Languageen
FieldMedicine
TopicBreast Implant and Reconstruction
Canadian institutionsnot available
Fundersnot available
KeywordsMEDLINESystematic reviewBreast cancerOutcomes researchRisk assessment

Abstract

fetched live from OpenAlex

Acellular dermal matrices (ADMs) such as human-derived AlloDerm and Cortiva are widely used in implant-based breast reconstruction (IBBR) to provide soft-tissue support. AlloDerm is considered a standard ADM, while Cortiva (and its thinner variant, Cortiva Silhouette) is a newer alternative that may offer cost advantages. Individual studies including a recent randomized trial suggest Cortiva is non-inferior to AlloDerm in terms of clinical outcomes, with some evidence of lower seroma rates, and reduced material cost with Cortiva. To date, no comprehensive synthesis has focused specifically on comparing AlloDerm versus Cortiva in breast reconstruction. This protocol describes a systematic review and meta-analysis to evaluate differences in surgical complications, patient-reported outcomes, and cost between AlloDerm and Cortiva. We will search MEDLINE (PubMed), Embase, Scopus, Web of Science, and the Cochrane Library for studies comparing AlloDerm to Cortiva in implant-based breast reconstruction. Both randomized controlled trials and observational studies (cohort or case–control designs) will be included. Two reviewers will independently screen titles/abstracts and full texts against predefined inclusion criteria, and extract data using a standardized form. Outcomes of interest include complication rates (seroma, infection, capsular contracture, implant malposition); patient-reported outcomes (BREAST-Q scores); revision or explantation surgeries; and cost measures. Study quality will be appraised using the Cochrane risk-of-bias tool for RCTs and the Newcastle–Ottawa Scale for observational studies. We will perform meta-analysis using random-effects models if ≥ 2 studies report comparable outcomes. Risk ratios or odds ratios will be pooled for dichotomous outcomes, and mean differences for continuous outcomes, with 95% confidence intervals. Heterogeneity will be assessed with the I2 statistic and Cochran Q test. Subgroup analyses will be performed to minimize confounding, and sensitivity analyses (e.g., excluding high risk-of-bias studies) are planned to assess robustness of findings. This review will synthesize the available evidence comparing AlloDerm and Cortiva ADMs in breast reconstruction. Given that a high-level RCT found no significant differences in overall failure or complications and multiple cohort studies indicate equivalent safety profiles, our meta-analysis will clarify if any true differences exist in complication rates or patient outcomes. We will also quantify any advantages of Cortiva in lowering costs. PROSPERO 2025 CRD420251078451. Available from https://www.crd.york.ac.uk/PROSPERO/view/CRD420251078451

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.805
Threshold uncertainty score0.760

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0040.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0110.002
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.122
GPT teacher head0.418
Teacher spread0.296 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueSystematic ReviewsSame topicBreast Implant and ReconstructionFrench-language works237,207